Pylarify (piflufolastat f 18) injections.

Ended Awarded Last action

Contract number
36C25925N0326
Awardee
Awarding agency
Obligated
$414,994

Award facts

Contract value 100% obligated
$414,994.08 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
North Billerica, Billerica, MA 01862, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00005 -$2,400
Supplemental Agreement for work within scope P00004 -$60,148
Supplemental Agreement for work within scope P00003 $51,713
Exercise an Option P00002 $173,219
Supplemental Agreement for work within scope P00001 $79,392
Original award $173,219

About this award

Veterans Integrated Service Network 19 issued a delivery order to Progenics Pharmaceuticals Inc. on April 4, 2025, with a ceiling value of $414,994.08 for supply of PYLARIFY (piflufolastat F-18) injections under the GSA Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The order is firm fixed price with no set-aside designation.

Place of performance is North Billerica, Massachusetts. Ultimate completion is April 3, 2026. PYLARIFY is a radiopharmaceutical diagnostic imaging agent for positron emission tomography scans used to detect and localize prostate cancer. Progenics, a division of Lantheus Medical Imaging, Inc., is the sole authorized manufacturer of this product for federal healthcare procurement.

Quick answers

Who was awarded contract 36C25925N0326?

36C25925N0326 was awarded to Progenics Pharmaceuticals Inc. by Veterans Integrated Service Network 19 (Veterans Health Administration) on April 4, 2025.

How much is contract 36C25925N0326 worth?

The government has obligated $414,994 on 36C25925N0326.

Is contract 36C25925N0326 an order under another contract?

Yes. 36C25925N0326 is a delivery order under 36F79725D0093, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36C25925N0326 competed?

The extent of competition for 36C25925N0326 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award